Skip to main content
. 2024 Jan 30;14:2485. doi: 10.1038/s41598-024-52942-3

Figure 3.

Figure 3

Mean difference in anatomical outcomes between intravitreal faricimab and control groups. (A) Central subfield thickness (µm). (B) Total CNV area (mm2). (C). Total lesion leakage (mm2).